NLRP3 and inflammatory bowel disease: In summary, nanomedicine leverages advanced delivery systems to target immune regulation in IBD, with a focus on macrophages and critical inflammatory pathways such as TNF-α, NF-κB, and NLRP3 inflammasome, providing a multifaceted and targeted strategy for IBD therapy.